stage iv prostate cancer

Showing 26 - 50 of 94

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer Trial in Duarte, Pasadena, Salt Lake City

Completed
  • Adenocarcinoma of the Prostate
  • +5 more
  • sipuleucel-T
  • +2 more
  • Duarte, California
  • +2 more
Aug 21, 2020

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer Trial (Image Guided Biopsy)

Withdrawn
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Image Guided Biopsy
  • (no location specified)
Jul 22, 2020

Castration-Sensitive Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer Trial in Salt Lake City

Terminated
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +5 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Jun 5, 2020

Bone Metastases, Castrate-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Chicago (drug, other, procedure)

Completed
  • Bone Metastases
  • +3 more
  • Chicago, Illinois
    University of Chicago
Mar 25, 2020

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Stanford (drug, radiation,

Completed
  • Adenocarcinoma of the Prostate
  • +5 more
  • sodium selenite
  • +4 more
  • Stanford, California
    Stanford University, School of Medicine
Feb 14, 2020

Prostate Adenocarcinoma, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Rochester (Goserelin Acetate, Laboratory

Terminated
  • Prostate Adenocarcinoma
  • +4 more
  • Goserelin Acetate
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Dec 9, 2019

Stage III Prostate Cancer, Stage IIIA Prostate Cancer, Stage IIIB Prostate Cancer Trial (biological, radiation, procedure)

Withdrawn
  • Stage III Prostate Cancer
  • +6 more
  • Ipilimumab
  • +3 more
  • (no location specified)
Nov 7, 2019

Stage IV Prostate Cancer, Stage IV Colon Cancer, Stage IV Breast Cancer Trial in Kingston (Dibenzyl trisulphide capsules, Stage

Unknown status
  • Stage IV Prostate Cancer
  • +3 more
  • Dibenzyl trisulphide capsules
  • +4 more
  • Kingston, Jamaica
    Faculty of Medial Sciences
Oct 3, 2019

Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Columbus, Dublin (dietary intervention

Completed
  • Stage I Prostate Cancer
  • +4 more
  • dietary intervention (tangerine tomato juice)
  • +3 more
  • Columbus, Ohio
  • +1 more
Aug 29, 2019

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in United States

Completed
  • Castration Levels of Testosterone
  • +3 more
  • Glycosylated Recombinant Human Interleukin-7
  • Laboratory Biomarker Analysis
  • La Jolla, California
  • +15 more
Jun 25, 2019

Castration-resistant Prostate Cancer, Stage IV Prostate Cancer Trial in Singapore, United States (abiraterone acetate)

Completed
  • Castration-resistant Prostate Cancer
  • Stage IV Prostate Cancer
  • abiraterone acetate
  • Atlanta, Georgia
  • +5 more
Jul 2, 2019

Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage II Prostate Cancer Trial in Richmond (intensity modulated

Completed
  • Adenocarcinoma of the Prostate
  • +4 more
  • intensity modulated external beam radiation therapy
  • Richmond, Virginia
  • +1 more
Jun 27, 2019

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (biological,

Completed
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Cixutumumab
  • +2 more
  • Chicago, Illinois
  • +3 more
May 21, 2019

Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory

Completed
  • Advanced Malignant Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jun 5, 2019

Prostate Adenocarcinoma, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Seattle (drug, radiation, other)

Completed
  • Prostate Adenocarcinoma
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 21, 2018

Adenocarcinoma of the Prostate, Castration-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Seattle (Cabozantinib)

Terminated
  • Adenocarcinoma of the Prostate
  • +4 more
  • Seattle, Washington
    Seattle Cancer Care Alliance/University of Washington
Nov 6, 2018

Adenocarcinoma of the Prostate, Bone Metastases, Soft Tissue Metastases Trial in Aurora (Ranolazine)

Completed
  • Adenocarcinoma of the Prostate
  • +6 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Nov 29, 2018

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in United States (drug,

Completed
  • Adenocarcinoma of the Prostate
  • +3 more
  • Hsp90 inhibitor STA-9090
  • +7 more
  • Baltimore, Maryland
  • +3 more
Aug 19, 2018

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (Laboratory

Completed
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Washington, District of Columbia
  • +19 more
Aug 13, 2018

Adenocarcinoma of the Prostate, Stage IV Prostate Cancer Trial in Detroit, Houston, Madison (cediranib maleate, docetaxel,

Terminated
  • Adenocarcinoma of the Prostate
  • Stage IV Prostate Cancer
  • cediranib maleate
  • +3 more
  • Detroit, Michigan
  • +3 more
Jul 13, 2018

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Baltimore (Dexamethasone,

Terminated
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Jul 11, 2018

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Canada, United States (drug,

Completed
  • Prostate Adenocarcinoma
  • +2 more
  • Fairbanks, Alaska
  • +169 more
Feb 23, 2018

Stage IV Prostate Cancer Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

Withdrawn
  • Stage IV Prostate Cancer
  • Antineoplaston therapy (Atengenal + Astugenal)
  • Houston, Texas
    Burzynski Clinic
Jan 29, 2018

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Philadelphia (Alisertib,

Completed
  • Adenocarcinoma of the Prostate
  • +3 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Nov 8, 2017

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in New Brunswick (,

Terminated
  • Adenocarcinoma of the Prostate
  • +2 more
  • placebo
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Oct 25, 2017